Alterations of the endocannabinoid system in autism spectrum disorder: a systematic review and meta-analysis
- 15 June 2025
- journal article
- review article
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 275 (8) , 2493-2509
Abstract
Dysregulation of the endocannabinoid system (ECS) might be related to autism spectrum disorder (ASD). This study conducts a meta-analysis on the dysregulation of the ECS across ASD animal models and individuals with ASD and systematically reviews the impact of these alterations in ASD animal models. Out of 47 papers assessed for eligibility, 16 animal studies and five human studies were included for narrative synthesis and seven and three for quantitative analysis, respectively. The results revealed a significant decrease in hippocampus anandamide (AEA) levels (SMD = −1.06, 95% CI [−1.78, −0.33], p < 0.01) among ASD animal models and a decrease in blood AEA levels in individuals with ASD (SMD = −0.79, 95% CI [−1.28, −0.30], p = 0.002) compared to normal controls. In the prefrontal cortex, 2-arachidonoylglycerol (2-AG) levels were significantly decreased, despite high heterogeneity between studies (SMD = −1.00, 95% CI [−1.93, −0.06], p = 0.04). No significant changes compared to normal controls were observed in levels of AEA (SMD = −0.48, 95% CI [−1.20, 0.25], p = 0.20), 2-AG (SMD = −0.62, 95% CI [−1.27, 0.02], p = 0.06) in combined brain regions. The narrative synthesis revealed that elevated AEA and 2-AG levels could ameliorate core and associated autistic-like symptoms with region and sex-dependent variations in ASD animal models. Future research should focus on specific mechanisms of endocannabinoids regional effects while considering sex-related influences.Keywords
Funding Information
- Nursing Science Research Fund of Peking University (TYZH2023002)
This publication has 74 references indexed in Scilit:
- Simultaneous UPLC–MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: Minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extractionJournal of Chromatography B, 2012
- Hippocampal integrity and neurocognition in first-episode schizophrenia: A multidimensional studyThe World Journal of Biological Psychiatry, 2011
- Supply and demand for endocannabinoidsTrends in Neurosciences, 2011
- Biosynthesis and degradation of the endocannabinoid 2‐arachidonoylglycerolBioFactors, 2010
- The Role of Endocannabinoid Signaling in Motor ControlPhysiology, 2010
- Behavioural phenotyping assays for mouse models of autismNature Reviews Neuroscience, 2010
- Hardwiring the Brain: Endocannabinoids Shape Neuronal ConnectivityScience, 2007
- The endocannabinoid system drives neural progenitor proliferationThe FASEB Journal, 2005
- The endocannabinoid system and its therapeutic exploitationNature Reviews Drug Discovery, 2004
- The molecular logic of endocannabinoid signallingNature Reviews Neuroscience, 2003